Department of Nephrology, Virgen de las Nieves Universitary Hospital, Granada, Spain.
Department of Nephrology, Virgen de las Nieves Universitary Hospital, Granada, Spain.
Transplant Proc. 2022 Jan-Feb;54(1):18-21. doi: 10.1016/j.transproceed.2021.08.060. Epub 2021 Nov 12.
Despite all efforts, the incidence of severe coronavirus disease 2019 (COVID-19) infection has been high in renal transplant recipients, as in other groups (eg, older adults, patients with comorbidities or immunosuppression). The detection of any possible predictor of gravity could improve the early approach in these patients.
We registered data from renal transplant recipients with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection in our area for a year (March 2020 to March 2021). We collected demographics, comorbidity, body mass index, lymphocyte count, and vitamin D levels before the diagnosis. We performed statistical analysis using SPSS Statistics version 20 (IBM Corp, Armonk, NY, United States).
Of 63 patients, 57.1% required hospital admission and 14.3% required intensive care. The incidence of acute renal failure was 28.6%; 34.9% developed hyperinflammatory syndrome; 67% had lymphopenia, which was severe in 13.1%; and 11 patients died. There was significant correlation between lymphocyte count before and during the infection. For hospitalization, we found differences in age, pulmonary disease, and renal function. Related factors for admission to an intensive care unit were obesity, severe lymphopenia, altered renal function, and low level of vitamin D. Predictors for mortality were age, renal function, and minimum lymphocyte count.
In kidney transplant recipients with COVID-19 infection, renal function determines hospitalization, and body mass index determines admission to an intensive care unit. Previous vitamin D levels are also significantly lower in patients requiring intensive care. The analysis of lymphocyte count previous to infection is correlated with the minimum level during the disease, which is a predictor of mortality, and could be a prognosis factor.
尽管已经付出了努力,肾移植受者(与其他群体一样,如老年人、合并症或免疫抑制患者)中严重 2019 年冠状病毒病(COVID-19)感染的发生率仍然很高。发现任何可能影响严重程度的预测因子都可以改善这些患者的早期治疗方法。
我们对本地区肾移植受者感染严重急性呼吸综合征冠状病毒 2 (SARS-COV-2)的数据进行了为期一年的登记(2020 年 3 月至 2021 年 3 月)。我们收集了诊断前的人口统计学资料、合并症、体重指数、淋巴细胞计数和维生素 D 水平。我们使用 SPSS Statistics 版本 20(IBM Corp,Armonk,NY,美国)进行统计分析。
在 63 例患者中,57.1%需要住院治疗,14.3%需要重症监护。急性肾衰竭的发生率为 28.6%;34.9%发生高炎症综合征;67%有淋巴细胞减少症,其中 13.1%为严重淋巴细胞减少症;11 例患者死亡。感染前后淋巴细胞计数存在显著相关性。住院的相关因素是年龄、肺部疾病和肾功能。入住重症监护病房的相关因素是肥胖、严重淋巴细胞减少症、肾功能改变和维生素 D 水平低。死亡的预测因素是年龄、肾功能和最低淋巴细胞计数。
在 COVID-19 感染的肾移植受者中,肾功能决定住院,而体重指数决定入住重症监护病房。以前的维生素 D 水平在需要重症监护的患者中也显著降低。感染前淋巴细胞计数的分析与疾病期间的最低水平相关,这是死亡率的预测因子,也可能是预后因素。